##plugins.themes.bootstrap3.article.main##

Background: Sudan, as a developing country, suffers from most of the risk factors related to the transmission of the hepatitis E virus (HEV).

Objective: This study aimed to determine the sero-frequency of HEV in cancer patients and healthcare workers and its associated risk factors.

Methods: A descriptive cross-sectional design was followed, recruited populations were 120 cancer patients and 120 healthcare workers. Sociodemographic data and risk factors of the study subject were collected using a questionnaire and patient records. HEV-specific anti-HEV IgM and IgG antibodies screened by a competitive ELISA technique. A Chi-square test was determined for the association between HEV IgG sero-positivity andsubject information.

Results: The percentage of cancer patients positive for anti-HEV IgG and IgM antibodies was 50% (60/120) and 6.7% (8/120) while for the healthcare workers group was 25.8% (31/120) and 4.2% (5/120) respectively. The most documented risk factors for HEV among cancer patients were consumption of raw meat 94.2% (113/120), contact with animals 88.3% (106/120), and history of blood transfusion 81.7% (98/120) while raw meat consumption was commonly found in 94.2% (113/120) of healthcare workers group. A significant association was observed between IgG sero-positive healthcare workers and consumption of raw meat (p-value = 0.005).

Conclusion: The HEV sero-positivity was found at a high rate in both study groups, which requires further studies on its prevalence, epidemiology, and prevention.

Downloads

Download data is not yet available.

Introduction

Hepatitis E virus (HEV) is the most common hepatitis virus transmitted through the gastrointestinal tract and a major cause of water-related epidemics in Asia, Africa, India and Mexico [1], [2]. Recorded cases of HEV infection worldwide are on the rise, including deaths among high-risk groups and asymptomatic cases [3], [4]. Given the mode of transmission of the virus, developing countries are the most affected [5].

Cancer is one of the greatest threats to life in the world, with frightening mortality rates, especially in third-world countries, where the quality of life is poor [6]. Reducing the prevalence of cancer is a difficult task, so the incidence to the disease is increasing in most countries of the world. Cancer studies indicated that a large proportion of cancer cases are associated with microbial diseases, an example of this is the relationship between hepatitis B virus protein and liver cancer development [7]. Like other hepatic viruses, HEV can destroy liver tissue, which can lead to pathological changes, such as regeneration of liver growth factors leading to neoplastic changes [8].

Hepatitis E virus can be diagnosed in its acute phase clinically, by detecting IgM and/or RNA. A recent surveillance recognized eight genotypes of HEV, of which HEV-1, 2, 3, 4, and 7 are related to humans only. Genotypes 1 and 2 have been encountered in outbreaks in lower-middle-income countries [9]. It is very clear that transmission of HEV is associated with occupation, such as exposure to pigs [10], [11] and sheep [12], so healthcare workers are at risk from contact with cases, including patients with hepatitis. In a separate study, we found high levels of HEV sero-frequency in pregnant Sudanese women, at a rate of 44% [13], although pregnancy weakens immunity, this high percentage also indicates community spread of HEV. Eventually, we can summarize several reasons why there is a need to control HEV infection such as the development of appropriate vaccine: 1) HEV is re-emerging even in developed countries such as Europe [14], 2) HEV can cause epidemic cases [15], 3) Increase cases around the world [16] and 4) the licensing of a vaccine against HEV, as in China [17]. This study aimed to detect sero-positivity of HEV IgG and IgM among Sudanese cancer patients and healthcare workers from Gezira State and to identify associated risk factors.

Methods

Design and Settings

This was a descriptive cross-sectional study aimed at investigating sero-positivity of HEV among cancer patients admitted to the National Cancer Institute, University of Gezira, and healthcare workers in Gezira State, Sudan from August 2016 to November 2018. Gezira State is well-populated and inhabited by a mixture of races and tribes from inside and outside Sudan. This study included the following localities: Greater Wad Medani, Elkamleen, El Managil, Southern of Gezira, Um-Alqura, Eastern Algezira, and Elhassahesa.

Study Population

The study included two groups: cancer patients and healthcare workers; cancer patients are previously diagnosed cases and receive treatment at the National Cancer Institute at the University of Gezira while the other group includes workers in healthcare from various localities in the Gezira State and with different jobs and educational levels. Participants’ data on socio-demographics and risk factors were obtained using a questionnaire and from patients’ records.

Sampling and Sero-Detection of HEV

The study was based on a non–probability convenience sampling technique during the attendance of cancer patients and healthcare workers in Gezira State. In total, 240 venous blood specimens were obtained (120 cancer patients and 120 healthcare workers), and serum was collected and stored at 20 °C until used. Specific anti-HEV IgM and IgG were quantitatively measured using a competitive enzyme-linked immune-sorbent assay (ELISA) (MIKROGEN GmbH-Germany) according to the manufacturer’s instructions.

Data Analysis

Descriptive analysis of frequencies and association of study variables was accomplished by SBSS computer program version 20. P-value of less than 0.05 is considered significant.

Ethical Approval

This study was approved by the Faculty of Medical Laboratory Sciences, University of Gezira, and Ministry of Health, Gezira State.

Results

Socio-Demographics and Risk Factors

There were 120 cancer patients, their ages ranged from 3 to 90 years, with an average of 50.2 years. The frequency of female patients 68.3% (82/120) was higher than that of males 31.7% (38/120). The cases came from all localities in the State, Eastern Al-Jazeera 21.7% (26/120) and Greater Wad Medani 21.7% (26/120) localities were the most mentioned. Residence in rural areas among cancer patients included in the study accounted for 69.2% (83/120). The illiteracy rate and the level of primary education together reached 55.8% (67/120). Wells were the most commonly used source of water with a percentage of 66.7% (80/120). Personal hygiene observations of participating patients found that 64.2% (77/120) of them had a poor level of hygiene (Table I). The most documented risk factors for HEV were consumption of raw meat 94.2% (113/120), contact with animals 88.3% (106/120), and history of blood transfusion 81.7% (98/120) while breast cancer was the predominated type with the percentage of 43.3% (52/120) (Table II).

Socio-demographic Frequency (%) Frequency of positive IgG p-value
Gender Male 38 (31.7) 21 0.432
Female 82 (68.3) 39
Total 120 (100) 60
Locality Elkamleen 2 (17) 2 0.481
Elhassaheasa 11 (9.2) 3
Eastern Algezira 26 (21.7) 12
Um Elqura & South Algezira 19 (15.8) 9
Greater wad medani 26 (21.7) 13
Elmanagil 15 (12.5) 9
Other 21 (17.5) 12
Total 120 (100) 60
Residence Urban 37 (30.8) 17 0.553
Rural 83 (69.2) 43
Total 120 (100) 60
Occupation House wife 53 (44.2) 25 0.486
Worker 33 (27.5) 19
Employee 22 (18.3) 12
Other 12 (10) 4
Total 120 (100) 60
Education Uneducated 40 (33.3) 18 0.110
level Primary 27 (22.5) 19
Secondary 28 (23.3) 13
University 25 (20.8) 10
Total 120 (100) 60
Water source Wells 80 (66.7) 40 0.951
River 19 (15.8) 9
Canals 21 (17.5) 11
Total 120 (100) 60
Hygiene Bad 77 (64.2) 36 0.341
Good 43 (35.8) 24
Total 120 (100) 60
Dietary intake Inside home 103 (85.8) 52 0.793
Outside home 17 (14.2) 8
Total 120 (100) 60
Table I. Socio-Demographics of Cancer Patients Subject (No. 120) and its Association with HEV IgG Positivity
Risk factor Frequency (%) Frequency of positive IgG p-value
Jaundice Yes 7 (5.8) 5 0.243
No 113 (94.2) 55
Total 120 (100) 60
History of Yes 13 (10.8) 4 0.142
viral hepatitis No 107 (89.2) 56
Total 120 (100) 60
History of blood Yes 98 (81.7) 46 0.157
transfusion No 22 (18.3) 14
Total 120 (100) 60
Consumption Yes 113 (94.2) 55 0.243
of raw meat No 7 (5.8) 5
Total 120 (100) 60
Animal Yes 106 (88.3) 54 0.570
contact No 14 (11.7) 6
Total 120 (100) 60
Type of CML 6 (5) 2 0.305
cancer Prostate 10 (8.3) 5
Breast 52 (43.3) 25
CLL 12 (10) 6
Ovary 9 (7.5) 4
Testis 4 (3.3) 4
Lymphomas 5 (4.2) 4
Esophagus 2 (1.7) 2
Other 20 (16.7) 8
Total 120 (100) 60
Table II. Clinical and Risk Factors of Cancer Patients Subject (No 120) and its Association with HEV IgG Positivity

For healthcare worker female participants, rural residence, employee occupation and university education represented 70% (84/120), 67.5% (81/120), 72.5% (87/120), and 83.3% (100/120) respectively (Table III). Raw meat consumption was commonly found in 94.2% (113/120) of participants (Table IV).

Socio-demographic Frequency (%) Frequency of positive IgG p-value
Gender Male 36 (30) 9 0.891
Female 84 (70) 22
Total 120 (100) 31
Locality Elkamleen 2 (1.7) 1 0.839
Elhassaheasa 10 (8.3) 3
Eastern Algezira 26 (21.7) 6
Um Elqura & South Algezira 19 (15.8) 4
Greater wad medani 26 (21.7) 9
Elmanagil 15 (12.5) 4
Other 22 (18.3) 4
Total 120 (100) 31
Residence Urban 39 (32.5) 11 0.680
Rural 81 (67.5) 20
Total 120 (100) 31
Occupation Worker 33 (27.5) 5 0.100
Employee 87 (72.5) 26
Total 120 (100) 31
Education level Secondary 20 (16.7) 5 0.926
University 100 (83.3) 26
Total 120 (100)
Water source Wells 80 (66.7) 21 0.883
River 40 (33.3) 10
Total 120 (100)
Hygiene Bad 0 (0) NA
Good 120 (100)
Total 120 (100)
Dietary intake In side home 34 (28.3) 6 0.198
Outside home 86 (71.7) 25
Total 120 (100) 31
Table III. Socio-Demographics of Healthcare Workers Subject (No. 120) and its Association with HEV IgG Positivity
Risk factor Frequency (%) Frequency of positive IgG p-value
Jaundice Yes 0 (0) NA
No 120 (100) 31
Total 120 (100) 31
History of viral hepatitis Yes 0 (0) NA
No 120 (100) 31
Total 120 (100) 31
History of blood transfusion Yes 0 (0) NA
No 120 (100) 31
Total 120 (100) 31
Consumption of raw meat Yes 113 (94.2) 26 0.005
No 7 (5.8) 5
Total 120 (100) 31
Animal contact Yes 0 (0) NA
No 120 (100) 31
Total 120 (100) 31
Job type Medical 14 (11.7) 5 0.222
Worker 26 (21.7) 10
Nurse 48 (40) 9
Laboratory 32 (26.6) 7
Total 120 (100) 31
Table IV. Risk Factors of Healthcare Workers Subject (No 120) and its Association with HEV IgG Positivity

HEV Sero-Detection

In cancer participants, HEV IgG sero-positivity was 50% (60/120) while IgM equal 6.7% (8/120), no association was observed between IgG sero-positivity and socio-demographics or risk factors. Positivity to both HEV IgG and IgM antibodies was recorded in seven patients and only 1 patient showed positive IgM and negative IgG.

HEV IgG and IgM sero-positive results of healthcare workers were 25.8% (31/120) and 4.2% (5/120) respectively. The five cases that showed positive HEV IgM were also positive for IgG antibodies. A significant association was found between IgG sero-positive subjects and consumption of raw meat (p-value 0.005) (Table IV).

Discussion

There is no doubt that the increase in cases of infection with HEV has made it a global health risk, especially in developing countries where there are many factors that contribute to the transmission of the disease [18]. The genetic variation of the HEV genotypes also helped in the transmission of the virus from animal sources such as pigs and sheep [19]. Very little has been studied about HEV in Sudan, and therefore there is no data available on the prevalence of the disease in the community and the existing genotypes, however, a large epidemic was documented in Sudan in the border region of Darfur in 2004 [20], [21].

This study examined the frequency of HEV antibodies in cancer patients and healthcare workers. Cancer and its treatment weaken the patients’ immunity and predispose them to various diseases [22] while medical settings expose workers to viral pathogens, especially in the presence of limited resources, environmental pollution, and the absence of necessary infection control precautions [23].

The results showed that the sero-frequency of HEV IgG in cancer patients was 32.5%, which is higher compared to the estimated global rate of 12.47% [3] and indicative of a multiple transmission scenario. Cancer diseases usually weaken the body’s immune lines, resulting in chemo or radiotherapy, in addition, a large number of cancer patients require blood transfusions, the latter represents one of the methods of transmission of HEV [24]–[26]. In the present study, we found that a large percentage (81.7%) of the cancer patients received blood. In this context, another study suggested the hypothesis that occult hepatitis B virus is mostly transmitted to patients with chronic kidney disease through blood transfusion [27].

According to the results of this study, HEV IgG positivity is not influenced by gender, age, place of residence, occupation, and educational levels. With some variation, other studies have published higher rates in men [28], [29] and rural individuals [30]. Differences in HEV IgG sero-positivity between urban and rural areas assume the presence of multiple risk factors in rural residence such as drinking river and canal water, and exposure to animals and soil [31], [32].

The current findings estimated the presence of anti-HEV IgM antibodies in 6.7% and 5% of cancer patients and healthcare workers, which is also more than the prevalence reported globally [3]. The reasons that explain the presence of anti-HEV IgG antibodies with a higher positivity than anti-HEV IgM are that HEV IgM is associated with acute illness and disappears in a short period, while HEV IgG remains for a longer period in the blood of the infected persons. IgG can also be detected in cases of exposure to the virus or previous infections [33].

Consumption of uncooked meat as one of the risk factors for transmission of HEV was recorded at high rates in both research groups, and more than that, it gave a significant association (p-value = 0.005) with the positivity of anti-HEV IgG antibodies in the healthcare workers, this because Sudanese people, like many others around the world, are accustomed to eating parts of sheep and cow meat without cooking. It is known that consumption of uncooked meat is a major cause of zoonosis [34] and some infectious diseases [35]. In general, the serological frequency of HEV among healthcare workers recorded in this study is an indicator of the extent of the spread of HEV in the community, so necessary precautions to limit the spread of the disease such as community surveys and vaccination studies should be activated.

Conclusion

In conclusion, the high sero-frequency of HEV among cancer patients and healthcare workers is a strong indicator of the endemicity of the virus in Sudan, which is a poor country with limited resources to confront infectious diseases. However, measures should be taken to prevent HEV transmission in community and healthcare settings, including the vaccination program.

Study Limitation

This study was limited by the lack of confirmatory identification of epidemic genotypes of HEV in antibody-positive cases and did not take into account other hepatitis indicators such as measurement of liver enzymes.

Metrics

Metrics Loading ...

References

  1. Pallerla SR, Harms D, Johne R, Todt D, Steinmann E, Schemmerer M, et al. Hepatitis E virus infection: circulation, molecular epidemiology, and impact on global health. Pathog. 2020 Oct 20;9(10):856.
    DOI  |   Google Scholar
  2. Schlosser J. Transmission and pathogenesis of hepatitis E virus infection in European wild boar and domestic pigs, and the establishment of a small animal model for hepatitis E. Doctoral dissertation, Bibliothek der Tierärztlichen Hochschule Hannover; 2015.
     Google Scholar
  3. Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM, et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 2020 Jul;40(7):1516–28.
    DOI  |   Google Scholar
  4. Pérez-Gracia MT, Suay-García B, Mateos-Lindemann ML. Hepatitis E and pregnancy: current state. Rev Med Virol. 2017 May;27(3):e1929.
    DOI  |   Google Scholar
  5. Khuroo MS, Khuroo MS, Khuroo NS. Transmission of hepatitis E virus in developing countries. Viruses. 2016 Sep 20;8(9):253.
    DOI  |   Google Scholar
  6. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese Med J. 2021 Apr 5;134(7):783–91.
    DOI  |   Google Scholar
  7. Schwabe RF, Jobin C. The microbiome and cancer. NatRevCancer. 2013 Nov;13(11):800–12.
    DOI  |   Google Scholar
  8. Atsama MA, Atangana PJ, Noah DN, Moundipa PF, Pineau P, Njouom R. Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: preliminary observations. Int J Infect Dis. 2017 Nov 1;64:4–8.
    DOI  |   Google Scholar
  9. Muñoz-Chimeno M, Bartúren S, García-Lugo MA, Morago L, Rodríguez Á., Galán JC, et al. Hepatitis E virus genotype 3 microbiological surveillance by the Spanish reference laboratory: geographic distribution and phylogenetic analysis of subtypes from 2009 to 2019. Euro Surveill. 2022 Jun 9;27(23):2100542.
    DOI  |   Google Scholar
  10. Wu JY, Lau EH, Lu ML, Guo C, Guo ZM, Yuan J, et al. An occupational risk of hepatitis E virus infection in the workers along the meat supply chains in Guangzhou, China. One Health. 2022 Jun 1;14:100376.
    DOI  |   Google Scholar
  11. De Schryver A, De Schrijver K, François G, Hambach R, van Sprundel M, TabibiR, et al. Hepatitis E virus infection: an emerging occupational risk? Occup Med. 2015 Nov 1;65(8):667–72.
    DOI  |   Google Scholar
  12. Mesquita JR, Santos-Ferreira N, Ferreira AS, Albuquerque C, Nobrega C, Esteves F, et al. Increased risk of hepatitis E virus infection in workers occupationally exposed to sheep. Transbound Emerg Dis. 2020 Sep;67(5):1918–21.
    DOI  |   Google Scholar
  13. Elsharif YE, Alfaki KO, Elawad SA, Ebraheem AA, Magzob M, Mohammed AE, et al. Frequency of HEV antibodies in pregnant women and its association with existent risk factors, Sudan: a crosssectional study. Microbiol Res J Int. 2023 Aug 16;33(6):1–7.
    DOI  |   Google Scholar
  14. Zahmanova G, Takova K, Tonova V, Koynarski T, Lukov LL, Minkov I, et al. The re-emergence of hepatitis E virus in Europe and vaccine development. Viruses. 2023 Jul 16;15(7):1558.
    DOI  |   Google Scholar
  15. Al-Shimari FH, Rencken CA, Kirkwood CD, Kumar R, Vannice KS, Stewart BT. Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives.BMCPublic Health. 2023 Jun 12;23(1):1120.
    DOI  |   Google Scholar
  16. Mrzljak A, Balen I, Barbic L, Ilic M, Vilibic-Cavlek T. Hepatitis E virus in professionally exposed: a reason for concern? World J Hepatol. 2021 Jul 7;13(7):723.
    DOI  |   Google Scholar
  17. Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vacc Immunother. 2015 Apr 3;11(4):908–14.
    DOI  |   Google Scholar
  18. Raji YE, Toung OP, Taib NM, Sekawi ZB. Hepatitis E virus: an emerging enigmatic and underestimated pathogen. Saudi J Biol Sci. 2022 Jan 1;29(1):499–512.
    DOI  |   Google Scholar
  19. Dalton HR, Saunders M, Woolson KL. Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history? J Virus Erad. 2015 Jan 1;1(1):23–9.
    DOI  |   Google Scholar
  20. Mérens A, Guérin PJ, Guthmann JP, Nicand E. Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of realtime reverse transcription-PCR analysis of dried blood spots. J Clin Microbiol. 2009 Jun;47(6):1931–3.
    DOI  |   Google Scholar
  21. Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis. 2006 Jun 15;42(12):1679–84.
    DOI  |   Google Scholar
  22. Jacqueline C, Tasiemski A, Sorci G, Ujvari B, Maachi F, Missé D, et al. Infections and cancer: the fifty shades of immunity hypothesis. BMC Cancer. 2017 Dec;17(1):1–1.
    DOI  |   Google Scholar
  23. Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018 Jun 1;68(6):1256–71.
    DOI  |   Google Scholar
  24. Cordes AK, Goudeva L, Lütgehetmann M, Wenzel JJ, Behrendt P, Wedemeyer H, et al. Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma. J Hepatol. 2022 Jan 1;76(1):46–52.
    DOI  |   Google Scholar
  25. Bi H, Yang R, Wu C, Xia J. Hepatitis E virus and blood transfusion safety. Epidemiol Infect. 2020;148:e158. doi: 10.1017/S0950268820001429.
    DOI  |   Google Scholar
  26. Cheung CK, Wong SH, Law AW, Law MF. Transfusiontransmitted hepatitis E: what we know so far?World J Gastroentero. 2022 Jan 1;28(1):47.
    DOI  |   Google Scholar
  27. Ahmed EA, Mohammed AE, Nour BY, Talha AA, Hamid Z, Elshafia MA, et al. The possibilities of chronic renal failure patients contracting occult hepatitis B virus infection, Sudan. Adv Microbiol. 2022 Mar 7;12(3):91–102.
    DOI  |   Google Scholar
  28. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol. 2010 Jan;48(1):317–8.
    DOI  |   Google Scholar
  29. Ren F, Zhao C, Wang L, Wang Z, Gong X, Song M, et al. Hepatitis E virus seroprevalence and molecular study among blood donors in China. Transfus. 2014 Mar;54(3pt2):910–7.
    DOI  |   Google Scholar
  30. Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, et al. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol. 2013 Nov 1;58(3):504–8.
    DOI  |   Google Scholar
  31. Zhang X, Cremers N, Hendrickx S, Debing Y, Roskams T, Coelmont L, et al. Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies. Antivir Res. 2023 Aug 1;216:105670.
    DOI  |   Google Scholar
  32. Kasorndorkbua C, Guenette DK, Huang FF, Thomas PJ, Meng XJ, Halbur PG. Routes of transmission of swine hepatitis E virus in pigs. J Clin Microbiol. 2004 Nov;42(11):5047–52.
    DOI  |   Google Scholar
  33. Boonyai A, Thongput A, Sisaeng T, Phumchan P, Horthongkham N, Kantakamalakul W, et al. Prevalence and clinical correlation of hepatitis E virus antibody in the patients’ serum samples from a tertiary care hospital in Thailand during 2015–2018. Virol J. 2021 Dec;18:1–1.
    DOI  |   Google Scholar
  34. Gazu L, Alonso S, Mutua F, Roesel K, Lindahl JF, Amenu K, et al. Foodborne disease hazards and burden in Ethiopia: A systematic literature review, 1990–2019. Front Sustain Food Syst. 2023 Feb 15;7:1058977.
    DOI  |   Google Scholar
  35. Lianou A, Panagou EZ, Nychas GJ. Meat safety—I foodborne pathogens and other biological issues. In: Lawrie’s Meat Science. Woodhead Publishing, 2023 Jan 1, pp. 549–90.
    DOI  |   Google Scholar